Home>
US Stocks>
Bristol-myers Squibb Co.

Bristol-myers Squibb Co. share price today

(BMY)

Bristol-myers Squibb Co. share price is $57.76 & ₹4,921.04 as on 25 Dec 2024, 2.30 'hrs' IST

$57.76

▲

0.18

(0.31%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Bristol-myers Squibb Co. share price in Dollar and Rupees. Guide to invest in Bristol-myers Squibb Co. from India. Also see the sentimental analysis on Indian investors investing in Bristol-myers Squibb Co.. Get details on the Indian mutual funds that are investing in Bristol-myers Squibb Co.. Get Analyst recommendations and forecasts along with all the Bristol-myers Squibb Co.'s financials.

Bristol-myers Squibb Co. share price movements

Today's Low: $57.03
Today's High: $57.80
$57.76
1.26%
Downside
Day's Volatility :1.33%
Upside
0.07%
52 Weeks Low: $39.35
52 Weeks High: $61.08
$57.76
31.87%
Downside
52 Weeks Volatility :35.58%
Upside
5.44%

Bristol-myers Squibb Co. Returns

Period	Bristol-myers Squibb Co.	Sector (Health Care)	S&P500
3 Months	15.24%	-9.0%	5.1%
6 Months	39.15%	-4.6%	10.3%
1 Year	12.79%	3.0%	26.5%
3 Years	-7.27%	0.0%	27.8%

Bristol-myers Squibb Co. Key Statistics

in dollars & INR

Previous Close	$57.58
Open	$57.41
Today's High	$57.8
Today's Low	$57.03
Market Capitalization	$117.1B
Today's Volume	$3.5M
52 Week High	$61.08
52 Week Low	$39.35
Revenue TTM	$47.4B
EBITDA	$19.2B
Earnings Per Share (EPS)	$-3.58
Dividend Yield	4.33%
Profit Margin	-15.3%
Quarterly Earnings Growth YOY	-0.36%
Return On Equity TTM	-31.33%

How to invest in Bristol-myers Squibb Co. from India?

It is very easy for Indian residents to invest directly in Bristol-myers Squibb Co. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bristol-myers Squibb Co. stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bristol-myers Squibb Co. or BMY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bristol-myers Squibb Co. or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bristol-myers Squibb Co. shares which would translate to 0.015 fractional shares of Bristol-myers Squibb Co. as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bristol-myers Squibb Co., in just a few clicks!

Returns in Bristol-myers Squibb Co. for Indian investors in Rupees

Investment Value

₹1,00,000

Bristol-myers Squibb Co. investment value today

Current value as on today

₹1,15,029

Returns

₹15,029

(+15.03%)

Returns from Bristol-myers Squibb Co. Stock

₹12,790 (+12.79%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Bristol-myers Squibb Co.

-4.0%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Bristol-myers Squibb Co. from India has reduced in the last 30 days as on Dec 26, 2024. -4.0% less purchase transactions for Bristol-myers Squibb Co. in the last 30 days versus the previous period.

35%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Bristol-myers Squibb Co. on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 35% more investors are searching Bristol-myers Squibb Co. in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Bristol-myers Squibb Co.

Name	Shares Held	Change in Shares	% of Assets
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	174712	11761.61	2.61%
Motilal Oswal S&P 500 Index Fund Direct Growth	17422	-10.10	0.23%

Global Institutional Holdings in Bristol-myers Squibb Co.

Vanguard Group Inc
9.30%
BlackRock Inc
7.82%
State Street Corp
4.58%
JPMorgan Chase & Co
3.84%
Charles Schwab Investment Management Inc
3.01%
FMR Inc
2.22%

Analyst Recommendation on Bristol-myers Squibb Co.

Hold

32%Buy

64%Hold

3%Sell

Based on 31 Wall street analysts offering stock ratings for Bristol-myers Squibb Co.(by analysts ranked 0 to 5 stars)

Based on 31 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Bristol-myers Squibb Co.

What analysts predicted

Upside of 5.45%

Current:

$57.76

Target:

$60.91

Insights on Bristol-myers Squibb Co.

Price Movement
In the last 3 months, BMY stock has moved up by 15.2%
Decreasing Revenue
Bristol-Myers Squibb Co. has experienced a decline in revenue over the past two quarters. The revenue decreased from $12.20 billion to $11.89 billion, showing an average drop of 2.5% per quarter.
Decreasing Net Profit
Bristol-Myers Squibb Co. has seen a decline in its net profit over the last two quarters. The profit dropped from $1.68 billion to $1.21 billion, reflecting an average decrease of 27.9% per quarter.
BMY vs LLY (1 yr)
In the last 1 year, Eli Lilly And Company has given 39.4% return, outperforming this stock by 27.1%
BMY vs LLY (3 yr)
In the last 3 years, Eli Lilly And Company has given 191.3% return, outperforming this stock by 198.2%
Price to Sales
Bristol-Myers Squibb Co. (BMY) has a Price-to-Sales Ratio of 2.5, meaning that for every $1 of sales, investors are willing to pay $2.5 for the company's stock. In comparison, investors are willing to pay $17.5 for every $1 of sales for Eli Lilly and Company. This indicates that investors value Bristol-Myers Squibb's sales significantly lower than those of Eli Lilly.

Bristol-myers Squibb Co. Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$22.6B	↑ 8.59%
Net Income	$5.0B	↑ 391.76%
Net Profit Margin	21.95%	↑ 17.1%

	FY19	Y/Y Change
Revenue	$26.1B	↑ 15.89%
Net Income	$3.4B	↓ 30.55%
Net Profit Margin	13.15%	↓ 8.8%

	FY20	Y/Y Change
Revenue	$42.5B	↑ 62.62%
Net Income	$-9.0B	↓ 361.56%
Net Profit Margin	-21.16%	↓ 34.31%

	FY21	Y/Y Change
Revenue	$46.4B	↑ 9.09%
Net Income	$7.0B	↓ 177.75%
Net Profit Margin	15.08%	↑ 36.24%

	FY22	Y/Y Change
Revenue	$46.2B	↓ 0.49%
Net Income	$6.3B	↓ 9.54%
Net Profit Margin	13.71%	↓ 1.37%

	FY23	Y/Y Change
Revenue	$45.0B	↓ 2.5%
Net Income	$8.0B	↑ 26.84%
Net Profit Margin	17.83%	↑ 4.12%

	Q2 FY23	Q/Q Change
Revenue	$11.2B	↓ 0.98%
Net Income	$2.1B	↓ 8.36%
Net Profit Margin	18.47%	↓ 1.48%

	Q3 FY23	Q/Q Change
Revenue	$11.0B	↓ 2.32%
Net Income	$1.9B	↓ 6.99%
Net Profit Margin	17.58%	↓ 0.89%

	Q4 FY23	Q/Q Change
Revenue	$11.5B	↑ 4.66%
Net Income	$1.8B	↓ 8.61%
Net Profit Margin	15.35%	↓ 2.23%

	Q1 FY24	Q/Q Change
Revenue	$11.9B	↑ 3.38%
Net Income	$-11.9B	↓ 775.99%
Net Profit Margin	-100.39%	↓ 115.74%

	Q2 FY24	Q/Q Change
Revenue	$12.2B	↑ 2.83%
Net Income	$1.7B	↓ 114.1%
Net Profit Margin	13.77%	↑ 114.16%

	Q3 FY24	Q/Q Change
Revenue	$11.9B	↓ 2.53%
Net Income	$1.2B	↓ 27.92%
Net Profit Margin	10.18%	↓ 3.59%

	FY18	Y/Y Change
Profit	$16.0B	↑ 8.86%

	FY19	Y/Y Change
Profit	$18.1B	↑ 12.82%

	FY20	Y/Y Change
Profit	$30.7B	↑ 70.17%

	FY21	Y/Y Change
Profit	$36.4B	↑ 18.54%

	FY22	Y/Y Change
Profit	$36.0B	↓ 1.16%

	FY23	Y/Y Change
Profit	$34.3B	↓ 4.74%

	Q2 FY23	Q/Q Change
Profit	$8.4B	↓ 4.8%

	Q3 FY23	Q/Q Change
Profit	$8.5B	↑ 1.32%

	Q4 FY23	Q/Q Change
Profit	$8.7B	↑ 3.22%

	Q1 FY24	Q/Q Change
Profit	$8.9B	↑ 2.3%

	Q2 FY24	Q/Q Change
Profit	$6.8B	↓ 23.87%

	Q3 FY24	Q/Q Change
Profit	$8.9B	↑ 31.38%

	FY18	Y/Y Change
Operating Cash Flow	$5.9B	↑ 12.61%
Investing Cash Flow	$-874.0M	↑ 1224.24%
Financing Cash Flow	$-3.5B	↓ 13.29%

	FY19	Y/Y Change
Operating Cash Flow	$8.1B	↑ 35.81%
Investing Cash Flow	$-9.8B	↑ 1017.85%
Financing Cash Flow	$7.6B	↓ 315.59%

	FY20	Y/Y Change
Operating Cash Flow	$14.1B	↑ 74.19%
Investing Cash Flow	$-10.9B	↑ 11.15%
Financing Cash Flow	$-1.2B	↓ 115.1%

	FY21	Y/Y Change
Operating Cash Flow	$16.2B	↑ 15.34%
Investing Cash Flow	$-538.0M	↓ 95.05%
Financing Cash Flow	$-16.2B	↑ 1309.56%

	FY22	Y/Y Change
Operating Cash Flow	$13.1B	↓ 19.38%
Investing Cash Flow	$-1.1B	↑ 97.4%
Financing Cash Flow	$-17.0B	↑ 4.55%

	FY23	Y/Y Change
Operating Cash Flow	$13.9B	↑ 6.08%
Investing Cash Flow	$-2.3B	↑ 116.1%
Financing Cash Flow	$-9.4B	↓ 44.49%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$1.9B	↓ 36.46%
Investing Cash Flow	$-329.0M	↑ 56.67%
Financing Cash Flow	$-2.2B	↓ 28.75%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$4.8B	↑ 151.78%
Investing Cash Flow	$-410.0M	↑ 24.62%
Financing Cash Flow	$-5.2B	↑ 137.46%

	Q4 FY23	Q/Q Change
Operating Cash Flow	$4.3B	↓ 10.5%
Investing Cash Flow	$-1.3B	↑ 228.29%
Financing Cash Flow	$967.0M	↓ 118.74%

	Q1 FY24	Q/Q Change
Operating Cash Flow	$2.8B	↓ 33.35%
Investing Cash Flow	$-19.6B	↑ 1357.5%
Financing Cash Flow	$14.6B	↑ 1414.37%

Bristol-myers Squibb Co. Technicals Summary

Sell

Neutral

Buy

Bristol-myers Squibb Co. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Bristol-myers Squibb Co. Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bristol-myers Squibb Co.	-1.67%	39.15%	12.79%	-7.27%	-9.37%
Eli Lilly And Company	0.8%	-12.47%	36.83%	185.79%	505.99%
Johnson & Johnson	-5.61%	0.03%	-6.72%	-14.04%	0.38%
Merck & Co. Inc.	-2.14%	-23.39%	-7.9%	29.88%	9.25%
Novo Nordisk A/s	-17.68%	-39.53%	-15.73%	56.53%	202.68%
Abbvie Inc	-0.63%	6.52%	16.22%	33.92%	103.34%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bristol-myers Squibb Co.	12.66	NA	1.98	0.91	-0.31	0.06	0.04	8.45
Eli Lilly And Company	85.46	85.46	0.75	13.14	0.65	0.14	0.01	15.83
Johnson & Johnson	24.11	24.11	0.87	9.96	0.21	0.08	0.03	29.14
Merck & Co. Inc.	20.81	20.81	0.07	7.74	0.28	0.11	0.03	17.58
Novo Nordisk A/s	29.62	29.62	1.31	22.84	0.89	0.21	0.02	27.07
Abbvie Inc	62.94	62.94	0.43	10.94	0.56	0.08	0.04	3.41

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bristol-myers Squibb Co.	Hold	$117.1B	-9.37%	12.66	-15.3%
Eli Lilly And Company	Buy	$715.6B	505.99%	85.46	20.48%
Johnson & Johnson	Buy	$351.2B	0.38%	24.11	16.74%
Merck & Co. Inc.	Buy	$251.6B	9.25%	20.81	19.23%
Novo Nordisk A/s	Buy	$294.1B	202.68%	29.62	35.01%
Abbvie Inc	Buy	$318.1B	103.34%	62.94	9.22%

Bristol-myers Squibb Co. Dividend announcements

Bristol-myers Squibb Co. Dividends March, 2025
In the quarter ending March,2025. Bristol-myers Squibb Co. has declared dividend of $0.62
Read More

About Bristol-myers Squibb Co.

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.

Organization	Bristol-myers Squibb Co.
Employees	34100
CEO	Dr. Christopher S. Boerner Ph.D.
Industry	Health Technology

Management People of Bristol-myers Squibb Co.

Name	Title
Dr. Christopher S. Boerner Ph.D.	CEO & Chairman
Mr. David V. Elkins	Executive VP & CFO
Ms. Sandra Leung Esq.	Executive VP & General Counsel
Mr. Samit Hirawat M.D.	Executive VP, Chief Medical Officer & Head of Development
Mr. Greg Meyers	Executive VP and Chief Digital & Technology Officer
Mr. Timothy Power	VP & Head of Investor Relations
Ms. Kimberly M. Jablonski	Chief Compliance & Ethics Officer
Ms. Ahn Amanda Poole	Executive Vice President & Chief Human Resources Officer
Dr. Joseph J. Eiden Jr.	Head of Medical Affairs
Mr. Adam Lenkowsky	Executive VP, Chief Commercialization Officer & Head of U.S. Oncology

Important FAQs about investing in Bristol-myers Squibb Co. from India :

What is Bristol-myers Squibb Co. share price today?

Bristol-myers Squibb Co. share price today stands at $57.76, Open: $57.41 ; Previous Close: $57.58 ; High: $57.80 ; Low: $57.03 ; 52 Week High: $61.08 ; 52 Week Low: $39.35. The stock opens at $57.41, after a previous close of $57.58. The stock reached a daily high of $57.80 and a low of $57.03, with a 52-week high of $61.08 and a 52-week low of $39.35.

Can Indians buy Bristol-myers Squibb Co. shares?

Yes, Indians can invest in the Bristol-myers Squibb Co. (BMY) from India.

With INDmoney, you can buy Bristol-myers Squibb Co. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bristol-myers Squibb Co. at zero transaction cost.

How can I buy Bristol-myers Squibb Co. shares from India?

It is very easy to buy Bristol-myers Squibb Co. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bristol-myers Squibb Co. be purchased?

Yes, you can buy fractional shares of Bristol-myers Squibb Co. with INDmoney app.

What are the documents required to start investing in Bristol-myers Squibb Co. stocks?

To start investing in Bristol-myers Squibb Co., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.